Heparin-binding epidermal growth factor-like growth factor antigen binding proteins

Details for Australian Patent Application No. 2008303796 (hide)

Owner Amgen Inc. U3 Pharma GmbH

Inventors Prenzel, Norbert; Rothe, Mike; Borges, Eric; Hettmann, Thore; Zwick-Wallasch, Esther; Foord, Orit

Agent Davies Collison Cave

Pub. Number AU-A-2008303796

PCT Pub. Number WO2009/040134

Priority 07018946.9 26.09.07 EP; 60/975,485 26.09.07 US

Filing date 26 September 2008

Wipo publication date 2 April 2009

International Classifications

C07K 16/22 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

A61K 33/24 (2006.01) Medicinal preparations containing inorganic active ingredients - Heavy metals

A61K 39/395 (2006.01) Medicinal preparations containing antigens or antibodies - Antibodies

A61P 35/00 (2006.01) Antineoplastic agents

C07K 16/28 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

Event Publications

20 May 2010 PCT application entered the National Phase

  PCT publication WO2009/040134 Priority application(s): WO2009/040134

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008303800-Method and system for transmitting data packets to multiple receivers

2008303794-Self-anchoring tissue lifting device and method of manufacturing said device